Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 8, 2001
Efficient and selective AAV2-mediated gene transfer directed to human vascular endothelial cellsS A Nicklin, H Buening, K L Dishart, et al.
Gene Therapy|January 22, 2005
Long-term preservation of retinal function in the RCS rat model of retinitis pigmentosa following lentivirus-mediated gene therapyM Tschernutter, F C Schlichtenbrede, S Howe, et al.
Gene Therapy|January 15, 2003
Novel antisense oligonucleotides targeting TGF-beta inhibit in vivo scarring and improve surgical outcomeM F Cordeiro, A Mead, R R Ali, et al.
Gene Therapy|September 7, 2012
RPE65 gene therapy slows cone loss in Rpe65-deficient dogsF M Mowat, A R Breuwer, J T Bartoe, et al.
Human Gene Therapy|October 30, 1999
High-titer recombinant adeno-associated virus production from replicating amplicons and herpes vectors deleted for glycoprotein HX Zhang, M De Alwis, S L Hart, et al.
Gene Therapy|November 25, 2011
Absence of ocular malignant transformation after sub-retinal delivery of rAAV2/2 or integrating lentiviral vectors in p53-deficient miceK S Balaggan, Y Duran, A Georgiadis, et al.
Gene Therapy|August 28, 2009
Gene therapy with a promoter targeting both rods and cones rescues retinal degeneration caused by AIPL1 mutationsX Sun, B Pawlyk, X Xu, et al.
Gene Therapy|June 27, 2008
Lentiviral-vector-mediated expression of murine IL-1 receptor antagonist or IL-10 reduces the severity of endotoxin-induced uveitisP Trittibach, S E Barker, C A Broderick, et al.
Gene Therapy|September 9, 2015
Photoreceptor rescue by an abbreviated human RPGR gene in a murine model of X-linked retinitis pigmentosaB S Pawlyk, O V Bulgakov, X Sun, et al.
Gene Therapy|October 7, 2006
Restoration of vision in RPE65-deficient Briard dogs using an AAV serotype 4 vector that specifically targets the retinal pigmented epitheliumG Le Meur, K Stieger, A J Smith, et al.
Pageof 8